PE000016

Name	R.CSDGWSFDATTLDDN[H5N4S2]GTMLFFK.G
Sequence	CSDGWSFDATTLDDNGTMLFFK
Glycans(s)	H5N4S2 (N15)
Mod(s)	57.021 (C1)
Molecular Weight	4749.850
Norm. RT	157.736
Protein	HPX (P02790)

Samples

Human Serum

DDA Transition Groups

	Exp. R.T.	Peak R.T.	Norm. R.T.	Prec. m/z	Prec. z	Inst.	Sample	Transitions
TG001480	74.455	74.120	157.117	1,183.971	4	Orbitrap	Human Serum	7
TG001099	74.152	74.083	158.356	1,578.292	3	Orbitrap	Human Serum	5
TG000620	74.842	74.144	156.859	1,578.292	3	Orbitrap	Human Serum	5
TG002670	76.626	74.580	158.405	1,183.971	4	Orbitrap	Human Serum	5
TG005097	77.352	77.503	165.334	1,183.971	4	Orbitrap	Human Serum	5
TG001460	74.455	74.120	157.117	1,578.292	3	Orbitrap	Human Serum	5
TG002644	76.626	74.610	158.483	1,578.292	3	Orbitrap	Human Serum	6

DIA Transition Groups

	Exp. R.T.	Peak R.T.	Norm. R.T.	Prec. m/z	Prec. z	Inst.	Sample	Intensity
TG008070	49.371	49.371	138.733	1,183.971	4	TripleTOF	Human Serum	3,775,490
TG008674	49.379	49.379	144.713	1,183.971	4	TripleTOF	Human Serum	3,427,390
TG008366	49.406	49.406	147.622	1,183.971	4	TripleTOF	Human Serum	3,359,980
TG008973	48.943	48.943	143.834	1,183.971	4	TripleTOF	Human Serum	2,744,990
TG009291	49.404	49.404	143.134	1,183.971	4	TripleTOF	Human Serum	2,420,980
TG010046	49.543	49.543	143.870	1,183.971	4	TripleTOF	Human Serum	1,444,540
TG009613	49.551	49.551	147.379	1,183.971	4	TripleTOF	Human Serum	1,013,200
TG010475	49.083	49.083	141.499	1,183.971	4	TripleTOF	Human Serum	807,375
TG007235	49.600	49.600	142.644	1,183.971	4	TripleTOF	Human Serum	39,077.4
TG006761	49.646	49.646	142.329	1,183.971	4	TripleTOF	Human Serum	35,886.9
TG007516	49.637	49.637	149.040	1,183.971	4	TripleTOF	Human Serum	34,011.7
TG007792	49.477	49.477	142.208	1,183.971	4	TripleTOF	Human Serum	33,852.5